Cargando…

Changes in white matter microstructure following serial ketamine infusions in treatment resistant depression

Ketamine produces fast‐acting antidepressant effects in treatment resistant depression (TRD). Though prior studies report ketamine‐related changes in brain activity in TRD, understanding of ketamine's effect on white matter (WM) microstructure remains limited. We thus sought to examine WM neuro...

Descripción completa

Detalles Bibliográficos
Autores principales: Taraku, Brandon, Woods, Roger P., Boucher, Michael, Espinoza, Randall, Jog, Mayank, Al‐Sharif, Noor, Narr, Katherine L., Zavaliangos‐Petropulu, Artemis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028677/
https://www.ncbi.nlm.nih.gov/pubmed/36715291
http://dx.doi.org/10.1002/hbm.26217
_version_ 1784909998437957632
author Taraku, Brandon
Woods, Roger P.
Boucher, Michael
Espinoza, Randall
Jog, Mayank
Al‐Sharif, Noor
Narr, Katherine L.
Zavaliangos‐Petropulu, Artemis
author_facet Taraku, Brandon
Woods, Roger P.
Boucher, Michael
Espinoza, Randall
Jog, Mayank
Al‐Sharif, Noor
Narr, Katherine L.
Zavaliangos‐Petropulu, Artemis
author_sort Taraku, Brandon
collection PubMed
description Ketamine produces fast‐acting antidepressant effects in treatment resistant depression (TRD). Though prior studies report ketamine‐related changes in brain activity in TRD, understanding of ketamine's effect on white matter (WM) microstructure remains limited. We thus sought to examine WM neuroplasticity and associated clinical improvements following serial ketamine infusion (SKI) in TRD. TRD patients (N = 57, 49.12% female, mean age: 39.9) received four intravenous ketamine infusions (0.5 mg/kg) 2–3 days apart. Diffusion‐weighted scans and clinical assessments (Hamilton Depression Rating Scale [HDRS‐17]; Snaith Hamilton Pleasure Scale [SHAPS]) were collected at baseline and 24‐h after SKI. WM measures including the neurite density index (NDI) and orientation dispersion index (ODI) from the neurite orientation dispersion and density imaging (NODDI) model, and fractional anisotropy (FA) from the diffusion tensor model were compared voxelwise pre‐ to post‐SKI after using Tract‐Based Spatial Statistics workflows to align WM tracts across subjects/time. Correlations between change in WM metrics and clinical measures were subsequently assessed. Following SKI, patients showed significant improvements in HDRS‐17 (p‐value = 1.8 E‐17) and SHAPS (p‐value = 1.97 E‐10). NDI significantly decreased in occipitotemporal WM pathways (p < .05, FWER/TFCE corrected). ΔSHAPS significantly correlated with ΔNDI in the left internal capsule and left superior longitudinal fasciculus (r = −0.614, p‐value = 6.24E‐09). No significant changes in ODI or FA were observed. SKI leads to significant changes in the microstructural features of neurites within occipitotemporal tracts, and changes in neurite density within tracts connecting the basal ganglia, thalamus, and cortex relate to improvements in anhedonia. NODDI may be more sensitive for detecting ketamine‐induced WM changes than DTI.
format Online
Article
Text
id pubmed-10028677
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-100286772023-03-22 Changes in white matter microstructure following serial ketamine infusions in treatment resistant depression Taraku, Brandon Woods, Roger P. Boucher, Michael Espinoza, Randall Jog, Mayank Al‐Sharif, Noor Narr, Katherine L. Zavaliangos‐Petropulu, Artemis Hum Brain Mapp Research Articles Ketamine produces fast‐acting antidepressant effects in treatment resistant depression (TRD). Though prior studies report ketamine‐related changes in brain activity in TRD, understanding of ketamine's effect on white matter (WM) microstructure remains limited. We thus sought to examine WM neuroplasticity and associated clinical improvements following serial ketamine infusion (SKI) in TRD. TRD patients (N = 57, 49.12% female, mean age: 39.9) received four intravenous ketamine infusions (0.5 mg/kg) 2–3 days apart. Diffusion‐weighted scans and clinical assessments (Hamilton Depression Rating Scale [HDRS‐17]; Snaith Hamilton Pleasure Scale [SHAPS]) were collected at baseline and 24‐h after SKI. WM measures including the neurite density index (NDI) and orientation dispersion index (ODI) from the neurite orientation dispersion and density imaging (NODDI) model, and fractional anisotropy (FA) from the diffusion tensor model were compared voxelwise pre‐ to post‐SKI after using Tract‐Based Spatial Statistics workflows to align WM tracts across subjects/time. Correlations between change in WM metrics and clinical measures were subsequently assessed. Following SKI, patients showed significant improvements in HDRS‐17 (p‐value = 1.8 E‐17) and SHAPS (p‐value = 1.97 E‐10). NDI significantly decreased in occipitotemporal WM pathways (p < .05, FWER/TFCE corrected). ΔSHAPS significantly correlated with ΔNDI in the left internal capsule and left superior longitudinal fasciculus (r = −0.614, p‐value = 6.24E‐09). No significant changes in ODI or FA were observed. SKI leads to significant changes in the microstructural features of neurites within occipitotemporal tracts, and changes in neurite density within tracts connecting the basal ganglia, thalamus, and cortex relate to improvements in anhedonia. NODDI may be more sensitive for detecting ketamine‐induced WM changes than DTI. John Wiley & Sons, Inc. 2023-01-30 /pmc/articles/PMC10028677/ /pubmed/36715291 http://dx.doi.org/10.1002/hbm.26217 Text en © 2023 The Authors. Human Brain Mapping published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Taraku, Brandon
Woods, Roger P.
Boucher, Michael
Espinoza, Randall
Jog, Mayank
Al‐Sharif, Noor
Narr, Katherine L.
Zavaliangos‐Petropulu, Artemis
Changes in white matter microstructure following serial ketamine infusions in treatment resistant depression
title Changes in white matter microstructure following serial ketamine infusions in treatment resistant depression
title_full Changes in white matter microstructure following serial ketamine infusions in treatment resistant depression
title_fullStr Changes in white matter microstructure following serial ketamine infusions in treatment resistant depression
title_full_unstemmed Changes in white matter microstructure following serial ketamine infusions in treatment resistant depression
title_short Changes in white matter microstructure following serial ketamine infusions in treatment resistant depression
title_sort changes in white matter microstructure following serial ketamine infusions in treatment resistant depression
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028677/
https://www.ncbi.nlm.nih.gov/pubmed/36715291
http://dx.doi.org/10.1002/hbm.26217
work_keys_str_mv AT tarakubrandon changesinwhitemattermicrostructurefollowingserialketamineinfusionsintreatmentresistantdepression
AT woodsrogerp changesinwhitemattermicrostructurefollowingserialketamineinfusionsintreatmentresistantdepression
AT bouchermichael changesinwhitemattermicrostructurefollowingserialketamineinfusionsintreatmentresistantdepression
AT espinozarandall changesinwhitemattermicrostructurefollowingserialketamineinfusionsintreatmentresistantdepression
AT jogmayank changesinwhitemattermicrostructurefollowingserialketamineinfusionsintreatmentresistantdepression
AT alsharifnoor changesinwhitemattermicrostructurefollowingserialketamineinfusionsintreatmentresistantdepression
AT narrkatherinel changesinwhitemattermicrostructurefollowingserialketamineinfusionsintreatmentresistantdepression
AT zavaliangospetropuluartemis changesinwhitemattermicrostructurefollowingserialketamineinfusionsintreatmentresistantdepression